Why Schering-Plough Corporation's Nasonex Bee Is to Blame for FDA's New Drug Ad Rules

BNET -- The FDA’s new proposed guidelines on drug advertising read like a full-employment act for medical copywriters and graphic designers: they control font size, white space, context, contrast, placement, background and the use of sections in ads.

Back to news